Quick Answer
LIFECORE BIOMEDICAL, INC. \DE\ reported Operating Income of -$17.25 million for fiscal year 2025.
LIFECORE BIOMEDICAL, INC. \DE\ Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$17.25M | -95.0% |
| 2024 | -$8.84M | +59.4% |
| 2023 | -$21.80M | -84.9% |
| 2022 | -$11.79M | -33.6% |
| 2021 | -$8.82M | +65.9% |
| 2020 | -$25.88M | -572.6% |
| 2019 | $5.47M | -59.7% |
| 2018 | $13.59M | -7.4% |
| 2017 | $14.67M | +171.1% |
| 2016 | -$20.63M | -211.7% |
| 2015 | $18.46M | -8.6% |
| 2014 | $20.19M | -18.8% |
| 2013 | $24.87M | +70.6% |
| 2012 | $14.58M | +81.5% |
| 2011 | $8.03M | +0.6% |
| 2010 | $7.98M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.07M | — | +66.0% |
| February 28, 2025 | -$9.03M | -908.8% | -360.9% |
| November 30, 2024 | -$1.96M | -32.1% | +83.1% |
| August 31, 2024 | -$11.58M | -34.5% | -1194.3% |
| February 29, 2024 | -$895.0K | +86.3% | +39.6% |
| November 30, 2023 | -$1.48M | +72.3% | +82.8% |
| August 31, 2023 | -$8.61M | -163.1% | -31.9% |
| February 28, 2023 | -$6.53M | +23.8% | -22.0% |
- LIFECORE BIOMEDICAL, INC. \DE\ showed a decrease of -95.0% in Operating Income compared to the prior fiscal year.
- Over the 2010–2025 period, LIFECORE BIOMEDICAL, INC. \DE\’s operating income has declined by 316.0% (from $7.98 million to -$17.25 million).
- The most recent figure is from LIFECORE BIOMEDICAL, INC. \DE\’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 7, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: